The drug targets 80 Million Patient Encounters in the U.S. Annually... Dec 31
Glenmark has also received tentative approval by the U.S. FDA for Gabapentin Enacarbil Extended-Release Tablets, the generic version of Horizant 1of Arbor Pharmaceuticals.... Dec 31
-Advertisements-